Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncology Report

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2013.2567PMID 23807572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are Hedgehog and Wnt/β-catenin pathways involved in hepatitis C virus-mediated EMT?

  2013cited by this paper
• Erbin inhibits TGF-β1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway

  2012cited by this paper
• Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells.

  2012cited by this paper
• Genome-Wide Screening Reveals an EMT Molecular Network Mediated by Sonic Hedgehog-Gli1 Signaling in Pancreatic Cancer Cells

  2012cited by this paper
• Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway

  2012cited by this paper
• EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

  2012cited by this paper
• Targeting the Hedgehog signaling pathway for cancer therapy

  2012cited by this paper
• PI3K, Erk Signaling in BMP7-Induced Epithelial-Mesenchymal Transition (EMT) of PC-3 Prostate Cancer Cells in 2- and 3-Dimensional Cultures

  2011cited by this paper
• Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells

  2011cited by this paper
• Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern.

  2011cited by this paper
• Epithelial-mesenchymal transition in ovarian cancer.

  2010cited by this paper
• Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.

  2010cited by this paper
• Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.

  2009cited by this paper
• The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".

  2009cited by this paper
• NF-kappaB links oestrogen receptor signalling and EMT.

  2007cited by this paper
• NF-κB links oestrogen receptor signalling and EMT

  2007cited by this paper
• Class III β‐tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia

  2007cited by this paper
• Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

  2007cited by this paper
• Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

  2007cited by this paper
• Tamoxifen resistance in MCF7 cells promotes EMT‐like behaviour and involves modulation of β‐catenin phosphorylation

  2006cited by this paper
• Migrating cancer stem cells — an integrated concept of malignant tumour progression

  2005cited by this paper
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

  2005cited by this paper
• Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways

  2005cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Acquisition of chemoresistance in a human ovarian carcinoma cell line is linked to a defect in cell cycle control

  1998cited by this paper

• Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer

  2023cites this paper
• Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations

  2022cites this paper
• Investigation of role of CpG methylation in some epithelial mesenchymal transition gene in a chemoresistant ovarian cancer cell line

  2022cites this paper
• Mechanisms of cancer cell death induction by paclitaxel: an updated review

  2022cites this paper
• Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer

  2021cites this paper
• Mechanisms of chemoresistance and approaches to overcome its impact in gynecologic cancers

  2021cites this paper
• Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response

  2021cites this paper
• Investigation of the Role of CpG Methylation in Epithelial Mesenchymal Transition Master Genes in a Chemoresistant Ovarian Cancer Cell line

  2021cites this paper
• GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway

  2021cites this paper
• Specific c ‐ Jun N ‐ Terminal Kinase Inhibitor , JNK ‐ IN ‐ 8 Suppresses Mesenchymal Profile of PTX ‐ Resistant MCF ‐ 7 Cells through Modulating PI 3 K / Akt , MAPK and Wnt Signaling

  2020cites this paper
• Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways

  2020cites this paper
• EDIL3 promotes epithelial–mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells

  2020cites this paper
• Nanoparticle delivery systems to combat drug resistance in ovarian cancer.

  2020cites this paper
• Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology

  2020cites this paper
• Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer

  2019cites this paper
• Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells

  2019cites this paper
• Anticancer drug screening: standardization of in vitro wound healing assay

  2019cites this paper
• miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer

  2019cites this paper
• OTT_A_231489 11805..11816

  2019cites this paper
• Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1

  2018cites this paper
• A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors

  2018cites this paper
• All‐trans retinoic acid reverses epithelial‐mesenchymal transition in paclitaxel‐resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions

  2018cites this paper
• Liposomal Combination Drug and siRNA Delivery to Combat Drug-Resistant Ovarian Cancer

  2018cites this paper
• LncRNAs and their role in cancer stem cells

  2017cites this paper
• Paclitaxel-loaded polymeric depots as injectable drug delivery system for cancer chemotherapy of hepatocellular carcinoma

  2017cites this paper
• Identification of licofelone through three-dimensional cell culture drug screening as a repurposed agent able to reverse drug resistant and cancer stem cell-like subpopulations in ovarian cancer

  2017cites this paper
• Epithelial‐to‐Mesenchymal Transition in Paclitaxel‐Resistant Ovarian Cancer Cells Is Downregulated by Luteolin

  2017cites this paper
• Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398

  2017cites this paper
• The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism

  2017cites this paper
• Inactivation of transforming growth factor-β-activated kinase 1 promotes taxol efficacy in ovarian cancer cells.

  2016cites this paper
• miR‐25‐3p reverses epithelial‐mesenchymal transition via targeting Sema4C in cisplatin‐resistance cervical cancer cells

  2016cites this paper
• Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma

  2016cites this paper
• Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer

  2016cites this paper
• Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells

  2016cites this paper
• Methylation of Notch3 modulates chemoresistance via P-glycoprotein.

  2016cites this paper
• The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers

  2016cites this paper
• Snail promotes epithelial-mesenchymal transition and invasiveness in human ovarian cancer cells.

  2015cites this paper
• The role of photodynamic therapy in overcoming cancer drug resistance

  2015cites this paper
• Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.

  2015cites this paper
• β-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cells.

  2015cites this paper
• Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines

  2014cites this paper
• MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells

  2014cites this paper
• The therapeutic potential of targeting the epithelial–mesenchymal transition in cancer

  2014cites this paper
• Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells

  2014influential citation
• MicroRNAs and drug resistance in prostate cancers.

  2014cites this paper
• Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer

  2014cites this paper
• Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance.

  2014cites this paper
• miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway

  2014cites this paper